Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study

Presse/Média: Research

Périodesept. 11 2023

Couverture média

1

Couverture média

  • TitreSona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study
    Nom du médiaBioSpace
    Pays/TerritoireUnited States
    Date9/11/23
    PersonnesCarman Anthony Giacomantonio